The use of an automated insulin delivery system is associated with a reduction in diabetes distress and improvement in quality of life in people with type 1 diabetes

Yves Reznik¹, Elisabeth Bonnemaison², Guy Fagherazzi³, Eric Renard^{4

5}, Hélène Hanaire⁶, Pauline Schaepelynck⁷, Mihaela Mihaileanu⁸, Jean-Pierre Riveline^{9

10}

Affiliations

¹ Endocrinology and Diabetes Department, CHU Côte de Nacre, Caen Cedex, France and Unicaen, Caen Cedex, France.
² Pediatrician Diabetologist, Department of Medicine, CHU de Tours and Clinique Saint Jean, Diabetology Department, Saint Jean de Vedas, Montpellier, France.
³ Deep Digital Phenotyping Research Unit, Department of Precision Health, Luxembourg Institute of Health, Strassen, Luxembourg.
⁴ Department of Endocrinology and Diabetes, Montpellier University Hospital, Montpellier, France.
⁵ Institute of Functional Genomics, University of Montpellier, CNRS, INSERM, Montpellier, France.
⁶ Diabetology Department, Rangueil, Toulouse University Hospital, Toulouse, France.
⁷ Diabetology Department, La Conception Hospital, Marseille University Hospital, Marseille, France.
⁸ Vitalaire, France.
⁹ Centre Universitaire du diabète et de ses complications, APHP, Hôpital Lariboisière, Paris, France.
¹⁰ Institut Necker Enfants Malades, INSERM U1151, CNRS UMR 8253, IMMEDIAB Laboratory, Paris, France.

PMID: 38253867
DOI: 10.1111/dom.15462

The use of an automated insulin delivery system is associated with a reduction in diabetes distress and improvement in quality of life in people with type 1 diabetes

Yves Reznik et al. Diabetes Obes Metab. 2024 May.

. 2024 May;26(5):1962-1966.

doi: 10.1111/dom.15462. Epub 2024 Jan 22.

Authors

Yves Reznik¹, Elisabeth Bonnemaison², Guy Fagherazzi³, Eric Renard^{4

5}, Hélène Hanaire⁶, Pauline Schaepelynck⁷, Mihaela Mihaileanu⁸, Jean-Pierre Riveline^{9

10}

Affiliations

¹ Endocrinology and Diabetes Department, CHU Côte de Nacre, Caen Cedex, France and Unicaen, Caen Cedex, France.
² Pediatrician Diabetologist, Department of Medicine, CHU de Tours and Clinique Saint Jean, Diabetology Department, Saint Jean de Vedas, Montpellier, France.
³ Deep Digital Phenotyping Research Unit, Department of Precision Health, Luxembourg Institute of Health, Strassen, Luxembourg.
⁴ Department of Endocrinology and Diabetes, Montpellier University Hospital, Montpellier, France.
⁵ Institute of Functional Genomics, University of Montpellier, CNRS, INSERM, Montpellier, France.
⁶ Diabetology Department, Rangueil, Toulouse University Hospital, Toulouse, France.
⁷ Diabetology Department, La Conception Hospital, Marseille University Hospital, Marseille, France.
⁸ Vitalaire, France.
⁹ Centre Universitaire du diabète et de ses complications, APHP, Hôpital Lariboisière, Paris, France.
¹⁰ Institut Necker Enfants Malades, INSERM U1151, CNRS UMR 8253, IMMEDIAB Laboratory, Paris, France.

PMID: 38253867
DOI: 10.1111/dom.15462

No abstract available

Keywords: automated insulin delivery; diabetes distress; hybrid closed loop; quality of life; type 1 diabetes.

PubMed Disclaimer

References

REFERENCES

1. Young‐Hyman D, de Groot M, Hill‐Briggs F, Gonzalez J, Hood K, Peyrot M. Psychosocial care for people with diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2016;39:2126‐2140.
1. Sturt J, Dennick K, Due‐Christensen M, McCarthy K. The detection and management of diabetes distress in people with type 1 diabetes. Curr Diab Rep. 2015;15(11):101.
1. Polonsky WH, Hood KK, Levy CJ, et al. How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: findings from the first investigation with the Omnipod® 5 system. Diabetes Res Clin Pract. 2022;190:109998.
1. Schneider‐Utaka AK, Hanes S, Boughton CK, et al. Patient‐reported outcomes for older adults on CamAPS FX closed loop system. Diabet Med. 2023;12:e15126.
1. Benioudakis ES, Karlafti E, Kalaitzaki A, et al. Comparison of the sensor‐augmented pump system with the advanced hybrid closed‐loop delivery system: quality of life, diabetes distress, and Glycaemic outcomes in a real‐life context. Curr Diabetes Rev. 2023;20. doi:10.2174/1573399820666230531161858

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

Grants and funding

Vitalaire

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

The use of an automated insulin delivery system is associated with a reduction in diabetes distress and improvement in quality of life in people with type 1 diabetes

Affiliations

The use of an automated insulin delivery system is associated with a reduction in diabetes distress and improvement in quality of life in people with type 1 diabetes

Authors

Affiliations

References

REFERENCES

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Medical